Replies to post #120185 on Biotech Values

[jq1234]

It could also be Shire's defense mechanism a la CEPH.

[rkrw]

Well enzyme replacement biologic drugs didn't fit with simple ADHD drugs either.

Interesting to me the planned IPO price was $18.00 and they were taken out at the equivalent of $18.60.

Great story though coming out of bankruptcy, major debacle to a success story. This is the former Organogenesis.